TY - JOUR T1 - Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic JF - BMJ Open Quality JO - BMJ Open Qual DO - 10.1136/bmjoq-2020-001333 VL - 10 IS - 2 SP - e001333 AU - Danielle Marie Goetz AU - Carla Frederick AU - Adrienne Savant AU - Alex Cogswell AU - Lynne Fries AU - Christine Roach AU - Nicole Shea AU - Drucy Borowitz AU - Beth Smith Y1 - 2021/05/01 UR - http://bmjopenquality.bmj.com/content/10/2/e001333.abstract N2 - Introduction Depression and anxiety are common. Rates are significantly higher in cystic fibrosis (CF), and impact health outcomes. Screening is recommended, but is difficult to implement/sustain annually in a busy CF centre. The aim was to develop an acceptable model for depression and anxiety screening in adolescents/adults with CF and their caregivers that could be sustained and shared.Methods Quality improvement methodology with plan-do-study-act cycles, flow diagrams, review of data monthly with our designated ‘Mental Health Team’ and caregiver satisfaction surveys, were used to begin screening in clinics and to improve the process. We then piloted our process at a larger paediatric CF centre.Results Prior to 2013, screening was not performed at our CF centre. After the first quarter of depression screening, 88% of adolescents and 69% of adults with CF were screened. The process was refined. By the second year, 99% of patients were screened. Anxiety screening began in year three; 97%–99% of patients were screened for both anxiety and depression in years 3–5. Annual caregiver screening rates were >95%. Screening was changed from Patient Health Questionnaire-2 (PHQ-2) to PHQ-9 due to better sensitivity in caregivers, and expanded to patients. Anxiety screening began in year 3 with the Generalised Anxiety Disorder-7 questionnaire. Patients and caregivers reported acceptance of screening. At the larger paediatric centre used as a pilot, 89.6% of patients were screened in year 1. Feedback included recommendations to improve tracking/follow-up of positive screens.Conclusions Development and implementation of a stepwise process for depression and anxiety screening was successful in a paediatric/adult CF clinic, due to constant re-evaluation by an engaged team with feedback from patients via survey. A systematic approach at a busy CF centre can serve as a model to implement screening in a clinic.Data are available upon request. ER -